Author

Vikki Ho

The University of SydneyPrimary ORCID profile (0000-0002-0724-7917 · 2 papers)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Vikki HoiD2 papers · American Cancer Society

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Organism:human· 1 Organism:mouse· 1 Approach:statistical model· 1

Frequent Co-Authors

Brian GlossiD· 1 shared Catherine L. WorthiD· 1 shared Christopher LiddleiD· 1 shared Daniele VitaleiD· 1 shared Duncan J. McLeodiD· 1 shared Geraint B. RogersiD· 1 shared Ghazal Alipour TaleshiD· 1 shared Jacob GeorgeiD· 1 shared

Activity by Year

2022-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Brian GlossORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Higher basal tumor immune activity coupled with a systemic immune response improves liver cancer outcomes

Ghazal Alipour Talesh, Daniele Vitale, Peter Langfelder, Mahmoud Karimi Azardaryany, Michael J. Berry, T. Grant Belgard, Jocelyn M. Choo, Geraint B. Rogers, Vikki Ho, Mehdi Ramezani–Moghadam, Suat Dervish, Joey Lai, Brian Gloss, Catherine L. Worth, Duncan J. McLeod, , Saeed Esmaili

The paper shows that stronger systemic and liver immune responses improve liver cancer outcomes by reducing tumor burden and correlating with better survival.

bioRxiv · Apr 16, 2022 · PreprintCancer Biology